Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for inflammatory knee osteoarthritis
ChiCTR2500101334Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Apr 2025
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of etanercept in knee osteoarthritis (OA) (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Level of pain. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
etanercept
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500101334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101334.